Breaking News Instant updates and real-time market news.

CDNA

CareDx

$23.56

-0.16 (-0.67%)

07:07
08/23/19
08/23
07:07
08/23/19
07:07

CareDx draft LCD should increase AlloSure test volumes, says H.C. Wainwright

After Palmetto GBA, the Medicare administrator responsible for the molecular diagnostic, or MolDX, technology assessment program issued a positive draft Local Coverage Determination for Medicare coverage in heart transplant patients for CareDx's AlloMap and AlloSure-Heart, H.C. Wainwright analyst Yi Chen said the draft determination should increase AlloSure test volume in heart transplant patients and validates the clinical value of CareDx's surveillance tests. He reiterates a Buy rating and $43 price target on CareDx shares.

  • 04

    Sep

CDNA CareDx
$23.56

-0.16 (-0.67%)

07/10/19
RAJA
07/10/19
NO CHANGE
Target $46
RAJA
Strong Buy
CareDx should get 'Trump Bump' from kidney care speech, says Raymond James
Noting that President Donald Trump is expected to discuss policies to increase the volume of organ transplants, including kidneys by 17,000 over time, in a speech scheduled for 11 am ET this morning, Raymond James analyst John Hsu said he anticipates a positive tailwind for organ transplants and a "Trump Bump" for CareDx. While Hsu said he thinks a target to nearly double the current kidney transplant rate is "undoubtedly an ambitious goal" and he sees a 13-15% increase in year one as more likely, he raised his revenue estimates for CareDx given an expected acceleration from the 5% typical increase in annual kidney transplants. He maintains a Strong Buy rating and $46 price target on CareDx shares.
07/11/19
CHLM
07/11/19
NO CHANGE
Target $48
CHLM
Buy
CareDx price target raised to $48 from $40 at Craig-Hallum
Craig-Hallum analyst Per Ostlund raised his price target for CareDx to $48 from $40 after President Trump signed an executive order to remake kidney care in the U.S., laying out a series of initiatives that clearly cement organ transplantation as a preferred treatment option for those suffering from kidney disease. While the initiatives will no doubt take some measure of time to translate into an increase in transplants, the analyst believes the order is an "unmitigated positive and wind at the back" for CareDx, which is involved in patient care across the transplant continuum. Ostlund reiterates a Buy rating on the shares.
08/02/19
PIPR
08/02/19
NO CHANGE
Target $63
PIPR
Overweight
CareDx price target raised to $63 from $50 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for CareDx to $63 from $50 citing the company's "big beat and raise" in Q2. AlloSure continues to lead overall performance, but with AlloMap growing double digits and the human leukocyte antigen reagents starting to ramp, the overall company is executing well, Quirk tells investors in a research note. CareDx shares remains his top small cap idea and he continues to be a buyer with an Overweight rating.
08/22/19
PIPR
08/22/19
NO CHANGE
Target $63
PIPR
Overweight
Piper Jaffray says Palmetto's LCD to expand CareDx's AlloSure coverage to heart
Piper Jaffray analyst William Quirk tells investors in a research note that he thinks the Local Coverage Determination for AlloSure cell-free DNA testing in heart transplant recipients by Medicare contractor Palmetto could be indicative of expanding AlloMap to kidney. The proposed LCD is an expansion of the cfDNA technology, proposing now covering the technology in heart transplants in addition to kidney transplants. Quirk says adoption of AlloSure is "strong," and CareDx is looking to increase its offerings to the transplant community. Quick maintains an Overweight rating and $63 price target on CareDx.

TODAY'S FREE FLY STORIES

NEWR

New Relic

$53.86

-4.48 (-7.68%)

12:01
09/16/19
09/16
12:01
09/16/19
12:01
Recommendations
New Relic analyst commentary  »

New Relic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$16.91

-1.94 (-10.29%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -10.2% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCO

Scor ADR

$13.52

-3.825 (-22.06%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Scor ADR falls -21.8% »

Scor ADR is down -21.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$4.37

-2.11 (-32.56%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Britannia Bulk falls -32.8% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$14.50

2.68 (22.67%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
California Resources rises 22.6% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$10.27

2.74 (36.39%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Whiting Petroleum rises 36.5% »

Whiting Petroleum is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

  • 09

    Oct

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.31

0.16 (0.18%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Options
Puts lead calls 15:1 in High Yield Bond ETF on vertical spread buyer »

Puts lead calls 15:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEMG

SemGroup

$16.82

6.54 (63.62%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
SemGroup rises 63.6% »

SemGroup is up 63.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:00
09/16/19
09/16
12:00
09/16/19
12:00
General news
Treasury's $87 B 3- and 6-month bill auction results were generally below average »

Treasury's $87 B 3-…

VLGEA

Village Super Market

$26.70

0.05 (0.19%)

11:53
09/16/19
09/16
11:53
09/16/19
11:53
Hot Stocks
Village Super Market board of directors authorizes $5M share repurchase program »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$52.62

0.875 (1.69%)

11:51
09/16/19
09/16
11:51
09/16/19
11:51
Upgrade
Total rating change  »

Total upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

OCN

Ocwen

$2.00

0.01 (0.50%)

11:50
09/16/19
09/16
11:50
09/16/19
11:50
Options
April call buyer in $2 stock Ocwen Financial »

April call buyer in $2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$18.42

8.37 (83.28%)

11:47
09/16/19
09/16
11:47
09/16/19
11:47
Downgrade
Alder Biopharmaceuticals rating change  »

Alder Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Feb

MET

MetLife

$47.56

-0.8 (-1.65%)

11:40
09/16/19
09/16
11:40
09/16/19
11:40
Options
Large call seller appears to average up on short calls in MetLife »

Large call seller appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

EQNR

Equinor

$20.16

0.72 (3.70%)

11:39
09/16/19
09/16
11:39
09/16/19
11:39
Upgrade
Equinor rating change  »

Equinor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

UBER

Uber

$34.57

1.33 (4.00%)

, LYFT

Lyft

$48.63

2.53 (5.49%)

11:37
09/16/19
09/16
11:37
09/16/19
11:37
On The Fly
Upgrades of Uber and Lyft, downgrade of HP among today's top analyst actions »

Check out today's top…

UBER

Uber

$34.57

1.33 (4.00%)

LYFT

Lyft

$48.63

2.53 (5.49%)

HPQ

HP Inc.

$18.82

-0.26 (-1.36%)

DKS

Dick's Sporting

$38.92

-0.1 (-0.26%)

ACB

Aurora Cannabis

$5.60

-0.34 (-5.72%)

WLL

Whiting Petroleum

$10.54

3.01 (39.97%)

JAG

Jagged Peak Energy

$8.43

0.96 (12.85%)

CDEV

Centennial Resource Development

$5.67

1.26 (28.57%)

SM

SM Energy

$11.64

2 (20.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

  • 26

    Sep

  • 08

    Oct

  • 09

    Oct

  • 13

    Nov

11:36
09/16/19
09/16
11:36
09/16/19
11:36
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:36
09/16/19
09/16
11:36
09/16/19
11:36
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

AEGN

Aegion

$21.25

0.06 (0.28%)

11:32
09/16/19
09/16
11:32
09/16/19
11:32
Hot Stocks
Aegion's Insituform awarded $6.9M wastewater pipeline rehabilitation contract »

Aegion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FXI

iShares China Large-Cap ETF

$41.57

-0.34 (-0.81%)

11:30
09/16/19
09/16
11:30
09/16/19
11:30
Options
Big winner takes gains and rolls strike up in China Largecap ETF »

Big winner takes gains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$0.00

(0.00%)

, BHGE

Baker Hughes

$23.04

0.315 (1.39%)

11:25
09/16/19
09/16
11:25
09/16/19
11:25
Hot Stocks
GE ceases to hold 50% of Baker Hughes voting power after secondary »

Baker Hughes, a GE…

BKR

Baker Hughes

$0.00

(0.00%)

BHGE

Baker Hughes

$23.04

0.315 (1.39%)

GE

General Electric

$9.38

0.04 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

LYFT

Lyft

$48.54

2.44 (5.29%)

11:25
09/16/19
09/16
11:25
09/16/19
11:25
Options
Lyft call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$57.83

-0.46 (-0.79%)

11:25
09/16/19
09/16
11:25
09/16/19
11:25
Conference/Events
Square participates in a luncheon meeting with Wedbush »

Advisor Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 27

    Oct

  • 06

    Nov

ATRA

Atara Biotherapeutics

$14.38

-0.78 (-5.15%)

11:25
09/16/19
09/16
11:25
09/16/19
11:25
Conference/Events
Atara Biotherapeutics participates in a conference call with JPMorgan »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

NBSE

NeuBase Therapeutics

$5.80

0.1 (1.75%)

11:25
09/16/19
09/16
11:25
09/16/19
11:25
Conference/Events
NeuBase Therapeutics to hold a KOL Meeting »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.